Announcements Trials
Browse Landscape

Phase

Phase 2 40Phase 3 18Phase NA 14Phase 1 5Phase 1/2 4Phase 2/3 3Phase 4 2

Status

Completed 4Unknown 3Active not recruiting 3Not yet recruiting 2Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 2Thoracic 1

Conditions

Nasopharyngeal Carcinoma 1Lung Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cisplatin 20Docetaxel 19Capecitabine 19Oxaliplatin 14Drug Therapy 14Cyclophosphamide 14Paclitaxel 13Fluorouracil 12Radiotherapy 11apatinib 9Gemcitabine 9Doxorubicin 9Decitabine 9Methotrexate 8Epirubicin 8Carboplatin 8sintilimab 6Etoposide 6camrelizumab 5anlotinib 5XELOX 5Sorafenib 5Radiation 5Pemetrexed 5Neoadjuvant Therapy 5Leucovorin 5Idarubicin 5Dexamethasone 5Cytarabine 5Busulfan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Unknown × Radiotherapy, Intensity-Modulated × Clear all
NCT05994339 2023-08-29

Radiotherapy Combined With Almonertinib for Stage III EGFR-Mutated Lung Cancer

Laibin People's Hospital

Phase 2/3 Unknown
40 enrolled
Thoracic

Lung Neoplasms

NCT00997906 2022-09-29

Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC

National Cancer Centre, Singapore

Phase 2/3 Unknown
172 enrolled
Head & Neck

Head and Neck Neoplasms

NCT01854203 2013-07-30

NPC

Sun Yat-sen University

Phase 2/3 Unknown
300 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡